Enviar noticia por correo electronico

Remitente:
Nombre: Email:
Destinatario:
Nombre: Email:


AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation

PR News | 13 may, 2026 09:15